AKERO THERAPEUTICS INC CVR from 00973Y108

13F holders, Q4 2025 (December 31)
3holders
$0.00avg. 13F price*

At the end of Q4 2025, 3 institutions reported holding AKERO THERAPEUTICS INC CVR from 00973Y108 in their 13F filings. The largest holders were Bessemer Group Inc. ($0), GAMMA Investing LLC ($0) and Keating Financial Advisory Services, Inc. ($0).

Company
AKERO THERAPEUTICS INC CVR from 00973Y108
CUSIP
009CVR044
Latest filing quarter
Q2 2026

History

Number of 13F holders

0123 Q4 2025: 3Q4 2025Q1 2026: 1Q1 2026Q2 2026: 1Q2 2026

Total Exit/New Position Q4 2025

InstitutionsTotal Value
New Positions2$0
Exits0$0

Ownership 3 holders

Bessemer Group Inc. 0.00% New 98 $0
GAMMA Investing LLC 0.00% New 452 $0
Keating Financial Advisory Services, Inc. 0.00% — 28 $0

"% of holder's portfolio" is AKERO THERAPEUTICS INC CVR from 00973Y108's weight in each manager's 13F, not the share of AKERO THERAPEUTICS INC CVR from 00973Y108 the manager owns.